We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+9.46%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$11.9B
AUM Growth
+$1.4B
(+13%)
Cap. Flow
+$748M
Cap. Flow
% of AUM
6.3%
Top 10 Holdings %
Top 10 Hldgs %
12.11%
Holding
747
New
202
Increased
220
Reduced
153
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASML
ASML
|
+$134M |
| 2 |
STMicroelectronics
STM
|
+$103M |
| 3 |
Meta Platforms (Facebook)
META
|
+$89.9M |
| 4 |
MetLife
MET
|
+$71.9M |
| 5 |
Gilead Sciences
GILD
|
+$70.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TE Connectivity
TEL
|
+$161M |
| 2 |
Eli Lilly
LLY
|
+$153M |
| 3 |
MRSH
Marsh
MRSH
|
+$123M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$91.8M |
| 5 |
Electronic Arts
EA
|
+$79.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 43.43% |
| 2 | Technology | 17.4% |
| 3 | Industrials | 8.07% |
| 4 | Energy | 6.4% |
| 5 | Financials | 6.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Jazz Pharmaceuticals
JAZZ
$16.4B
| $31.1M | 0.26% |
279,208
+276,619
| +10,684% | +$30.3M |
|
|
ANSS
127
DELISTED
Ansys
ANSS
| $30.6M | 0.26% |
96,021
+36,000
| +60% | +$11.4M |
|
128
DaVita
DVA
$14.6B
| $30.5M | 0.26% |
186,109
-28,702
| -13% | -$4.24M |
|
129
Arthur J. Gallagher & Co
AJG
$63.6B
| $29.9M | 0.25% |
106,306
-270,963
| -72% | -$76.4M |
|
130
Comcast
CMCSA
$88.5B
| $29.9M | 0.25% |
715,555
-30,599
| -4% | -$1.21M |
|
131
Kenvue
KVUE
$37.5B
| $29.7M | 0.25% |
1,285,889
-26,856
| -2% | -$556K |
|
132
Sun Communities
SUI
$15B
| $29.3M | 0.25% |
+217,017
| New | +$28.5M |
|
133
Procore
PCOR
$8.49B
| $29.3M | 0.25% |
+474,629
| New | +$29.1M |
|
134
Walt Disney
DIS
$170B
| $28.6M | 0.24% |
297,438
+212,464
| +250% | +$19.5M |
|
135
ATI
ATI
$27.3B
| $28.6M | 0.24% |
427,433
-52,570
| -11% | -$3.26M |
|
136
Immatics
IMTX
$1.28B
| $28.5M | 0.24% |
2,501,962
-760,048
| -23% | -$9M |
|
137
DuPont de Nemours
DD
$19.3B
| $28.4M | 0.24% |
253,697
+53,883
| +27% | +$5.49M |
|
138
Zevra Therapeutics
ZVRA
$622M
| $28.1M | 0.24% |
4,048,653
+2,901,070
| +253% | +$19.7M |
|
|
EDR
139
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $28M | 0.24% |
979,999
-120,000
| -11% | -$3.3M |
|
140
HealthEquity
HQY
$8.78B
| $27.6M | 0.23% |
336,783
+61,587
| +22% | +$4.75M |
|
141
Fox Class A
FOXA
$24.8B
| $27.1M | 0.23% |
639,353
-453,464
| -41% | -$17.6M |
|
142
Chipotle Mexican Grill
CMG
$42.8B
| $26.9M | 0.23% |
467,300
-112,765
| -19% | -$6.24M |
|
|
143
Electronic Arts
EA
$52.9B
| $26.9M | 0.23% |
187,407
-547,965
| -75% | -$79.5M |
|
144
Labcorp
LH
$25.3B
| $26.9M | 0.23% |
+120,261
| New | +$26.4M |
|
145
Axsome Therapeutics
AXSM
$10.9B
| $26.8M | 0.23% |
298,569
-19,442
| -6% | -$1.7M |
|
|
EXAS
146
DELISTED
Exact Sciences
EXAS
| $26.7M | 0.22% |
391,455
+334,995
| +593% | +$18.9M |
|
147
Capri Holdings
CPRI
$1.9B
| $26.3M | 0.22% |
620,002
+19,802
| +3% | +$694K |
|
148
Host Hotels & Resorts
HST
$17.1B
| $26.2M | 0.22% |
+1,491,474
| New | +$25.9M |
|
149
Exelixis
EXEL
$14.1B
| $25.8M | 0.22% |
993,130
+6,036
| +0.6% | +$150K |
|
|
ESGR
150
DELISTED
Enstar Group
ESGR
| $25.7M | 0.22% |
+80,000
| New | +$25.9M |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q3 2024 Portfolio in Review
As of Q3 2024, Woodline Partners held 747 positions worth $11.9B, up 13% from $10.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Woodline Partners deployed $748M of net new capital in Q3 2024, opening 202 new positions and adding to 220 existing holdings. Its largest new stake was ASML: 149,876 shares worth $125M.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 42% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Eli Lilly, an estimated $153M trimmed.
- Woodline Partners's largest Q3 2024 buy was ASML: 149,876 shares worth $125M.
- Woodline Partners added most to STMicroelectronics in Q3 2024, an estimated $103M increase.
- Woodline Partners's biggest Q3 2024 reduction was Eli Lilly, cutting an estimated $153M.
- Woodline Partners fully exited TE Connectivity in Q3 2024, selling an estimated $161M.
- Woodline Partners's ten largest holdings make up 12% of its $11.9B portfolio in Q3 2024.
- Woodline Partners opened 202 new positions and closed 161 in Q3 2024.
- Woodline Partners's portfolio value rose 13% quarter-over-quarter to $11.9B.
Based on Woodline Partners's 13F filing for Q3 2024, filed 14 Nov 2024.